155 related articles for article (PubMed ID: 20497425)
41. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
Hsi LC; Xi X; Lotan R; Shureiqi I; Lippman SM
Cancer Res; 2004 Dec; 64(23):8778-81. PubMed ID: 15574791
[TBL] [Abstract][Full Text] [Related]
42. Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner.
Li Q; Ding C; Meng T; Lu W; Liu W; Hao H; Cao L
J Pharmacol Sci; 2017 Dec; 135(4):148-155. PubMed ID: 29233468
[TBL] [Abstract][Full Text] [Related]
43. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity.
Choi YH
Int J Oncol; 2006 Nov; 29(5):1207-13. PubMed ID: 17016653
[TBL] [Abstract][Full Text] [Related]
44. Characterization of four clones derived from human adenocarcinoma cell line, HT29, and analysis of their response to sodium butyrate.
Stokrová J; Sloncová E; Sovová V; Kucerová D; Zíla V; Turecková J; Vojtechová M; Korb J; Tuhácková Z
Int J Oncol; 2006 Feb; 28(2):559-65. PubMed ID: 16391813
[TBL] [Abstract][Full Text] [Related]
45. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
Zopf S; Neureiter D; Bouralexis S; Abt T; Glaser KB; Okamoto K; Ganslmayer M; Hahn EG; Herold C; Ocker M
Int J Oncol; 2007 Dec; 31(6):1391-402. PubMed ID: 17982666
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
Karasawa Y; Okisaka S
Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
[TBL] [Abstract][Full Text] [Related]
47. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors.
Jiao J; Fang H; Wang X; Guan P; Yuan Y; Xu W
Eur J Med Chem; 2009 Nov; 44(11):4470-6. PubMed ID: 19608304
[TBL] [Abstract][Full Text] [Related]
49. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
Kim J; Park H; Im JY; Choi WS; Kim HS
Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
[TBL] [Abstract][Full Text] [Related]
50. Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
Chiaro C; Lazarova DL; Bordonaro M
Biochem Biophys Res Commun; 2012 Nov; 428(1):121-6. PubMed ID: 23063976
[TBL] [Abstract][Full Text] [Related]
51. A proteomic analysis of differential cellular responses to the short-chain fatty acids butyrate, valerate and propionate in colon epithelial cancer cells.
Kilner J; Waby JS; Chowdry J; Khan AQ; Noirel J; Wright PC; Corfe BM; Evans CA
Mol Biosyst; 2012 Apr; 8(4):1146-56. PubMed ID: 22075547
[TBL] [Abstract][Full Text] [Related]
52. Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis.
Bailón E; Cueto-Sola M; Utrilla P; Rodríguez-Cabezas ME; Garrido-Mesa N; Zarzuelo A; Xaus J; Gálvez J; Comalada M
Immunobiology; 2010 Nov; 215(11):863-73. PubMed ID: 20149475
[TBL] [Abstract][Full Text] [Related]
53. Proliferation and cellular death of A375 cell line in the presence of HDACs inhibitors.
Chodurek E; Orchel A; Gawlik N; Kulczycka A; Gruchlik A; Dzierzewicz Z
Acta Pol Pharm; 2010; 67(6):686-9. PubMed ID: 21229888
[No Abstract] [Full Text] [Related]
54. Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures.
Bigioni M; Ettorre A; Felicetti P; Mauro S; Rossi C; Maggi CA; Marastoni E; Binaschi M; Parlani M; Fattori D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5360-2. PubMed ID: 22877635
[TBL] [Abstract][Full Text] [Related]
55. Histone-deacetylase inhibition and butyrate formation: Fecal slurry incubations with apple pectin and apple juice extracts.
Waldecker M; Kautenburger T; Daumann H; Veeriah S; Will F; Dietrich H; Pool-Zobel BL; Schrenk D
Nutrition; 2008 Apr; 24(4):366-74. PubMed ID: 18262392
[TBL] [Abstract][Full Text] [Related]
56. Butyrate suppresses murine mast cell proliferation and cytokine production through inhibiting histone deacetylase.
Zhang H; Du M; Yang Q; Zhu MJ
J Nutr Biochem; 2016 Jan; 27():299-306. PubMed ID: 26601598
[TBL] [Abstract][Full Text] [Related]
57. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate.
Fung KY; Cosgrove L; Lockett T; Head R; Topping DL
Br J Nutr; 2012 Sep; 108(5):820-31. PubMed ID: 22676885
[TBL] [Abstract][Full Text] [Related]
58. The Australian fruit Illawarra plum (Podocarpus elatus Endl., Podocarpaceae) inhibits telomerase, increases histone deacetylase activity and decreases proliferation of colon cancer cells.
Symonds EL; Konczak I; Fenech M
Br J Nutr; 2013 Jun; 109(12):2117-25. PubMed ID: 23069328
[TBL] [Abstract][Full Text] [Related]
59. Hypothesis: butyrate is not an HDAC inhibitor, but a product inhibitor of deacetylation.
Corfe BM
Mol Biosyst; 2012 Jun; 8(6):1609-12. PubMed ID: 22446977
[TBL] [Abstract][Full Text] [Related]
60. Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate.
Lazarova DL; Bordonaro M; Carbone R; Sartorelli AC
Int J Cancer; 2004 Jul; 110(4):523-31. PubMed ID: 15122584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
